Clegg LE, Penland RC, Bachina S, Boulton DW, Thuresson M, Heerspink HJL, et al
Low-Frequency and Rare Exome Chip Variants Associate with Fasting Glucose and Type 2 Diabetes Susceptibility. Nature Communications, vol
Engineering a potent and long-acting GLP-1/Y2 receptor dual agonist as a multi-agonist therapy for diabetes and obesity
It undergoes significant first-pass metabolism in the liver and intestines, where the enzyme arginase breaks it down, reducing bioavailability
To make a larger batch, use 1 tsp peroxide and 10 tbs saline
For tarmspecifika applikationer kan oral administrering overvagas -- BPC-157 behaller stabilitet i magsaftsmiljon, vilket mojliggor direkt slemhinnekontakt langs GI-kanalen